American International Group, Inc. Y M Abs Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.57 - $18.69 $1,018 - $2,896	-155 Reduced 0.85%	18,132 $294,000
Q4 2023 Feb 13, 2024	SELL	$4.88 - $7.42 $361 - $549	-74 Reduced 0.4%	18,287 $124,000
Q3 2023 Nov 13, 2023	BUY	$4.86 - $7.23 $3,173 - $4,721	653 Added 3.69%	18,361 $100,000
Q2 2023 Aug 04, 2023	SELL	$5.68 - $10.34 $68 - $124	-12 Reduced 0.07%	17,708 $120,000
Q1 2023 May 12, 2023	BUY	$2.83 - $5.11 $1,001 - $1,808	354 Added 2.04%	17,720 $88,000
Q4 2022 Feb 10, 2023	SELL	$3.0 - $15.17 $192 - $970	-64 Reduced 0.37%	17,366 $84,000
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $3,434 - $4,838	246 Added 1.43%	17,430 $251,000
Q2 2022 Aug 12, 2022	SELL	$8.22 - $15.13 $1,364 - $2,511	-166 Reduced 0.96%	17,184 $260,000
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $8,004 - $21,287	-1,222 Reduced 6.58%	17,350 $206,000
Q4 2021 Feb 11, 2022	SELL	$15.51 - $29.31 $8,623 - $16,296	-556 Reduced 2.91%	18,572 $301,000
Q3 2021 Nov 12, 2021	SELL	$27.47 - $37.31 $12,471 - $16,938	-454 Reduced 2.32%	19,128 $546,000
Q2 2021 Aug 13, 2021	BUY	$25.45 - $37.64 $45,784 - $67,714	1,799 Added 10.12%	19,582 $662,000
Q1 2021 May 07, 2021	BUY	$29.16 - $51.96 $1,370 - $2,442	47 Added 0.26%	17,783 $538,000
Q4 2020 Feb 12, 2021	SELL	$37.86 - $54.26 $6,398 - $9,169	-169 Reduced 0.94%	17,736 $878,000
Q3 2020 Nov 04, 2020	SELL	$35.13 - $43.62 $14,262 - $17,709	-406 Reduced 2.22%	17,905 $687,000
Q2 2020 Aug 12, 2020	BUY	$23.66 - $49.53 $102,116 - $213,771	4,316 Added 30.84%	18,311 $791,000
Q1 2020 May 04, 2020	SELL	$14.39 - $35.8 $11,655 - $28,997	-810 Reduced 5.47%	13,995 $365,000
Q4 2019 Feb 05, 2020	BUY	$23.81 - $33.78 $46,548 - $66,039	1,955 Added 15.21%	14,805 $463,000
Q3 2019 Nov 08, 2019	SELL	$21.57 - $31.37 $1,919 - $2,791	-89 Reduced 0.69%	12,850 $335,000
Q2 2019 Aug 13, 2019	BUY	$19.51 - $28.31 $165,795 - $240,578	8,498 Added 191.35%	12,939 $296,000
Q1 2019 May 06, 2019	SELL	$18.21 - $26.21 $2,622 - $3,774	-144 Reduced 3.14%	4,441 $116,000
Q4 2018 Feb 13, 2019	BUY	$15.41 - $28.92 $70,654 - $132,598	4,585 New	4,585 $93,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

Paradigm Biocapital Advisors LP New York, NY

4.09M
Shares

$33.3 Million
1.93% of portfolio
Black Rock Inc. New York, NY

2.94M
Shares

$24 Million
0.0% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.19M
Shares

$17.9 Million
2.73% of portfolio
Vanguard Group Inc Valley Forge, PA

2.04M
Shares

$16.6 Million
0.0% of portfolio
Polar Capital Holdings PLC London, X0

1.83M
Shares

$14.9 Million
0.15% of portfolio

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account